Fragkioudaki et al identified patients with Sjogren's syndrome who are at risk for developing non-Hodgkin's lymphoma. The authors are from National and Kapodistrian University of Athens.
Patient selection: Sjogren's syndrome
Outcome: non=Hodgkin's lymphoma
Parameters:
(1) salivary gland enlargement
(2) lymphadenopathy
(3) Raynaud's phenomenon
(4) anti-Ro/SSA and/or anti-La/SSB positivity
(5) rheumatoid factor present
(6) monoclonal gammopathy
(7) C4-hypcomplementemia
Parmeter |
Finding |
LR Model |
Point Count |
salivary gland enlargement |
absent |
0 |
0 |
|
present |
1.456 |
1 |
lymphadenopathy |
absent |
0 |
0 |
|
present |
1.445 |
1 |
Raynaud's phenomenon |
absent |
0 |
0 |
|
present |
0.831 |
1 |
anti-Ro/SSA and/or anti-La/SSB |
absent |
0 |
0 |
|
present |
1.328 |
1 |
rheumatoid factor |
absent |
0 |
0 |
|
present |
1.305 |
1 |
monoclonal gammopathy |
absent |
0 |
0 |
|
present |
1.158 |
1 |
C4 hypocomp-lementemia |
absent |
0 |
0 |
|
present |
1.088 |
1 |
X =
= SUM(points for LR model) - (coefficient)
probability of lymphoma =
= 1 / (1 + EXP((-1) * X))
Unfortunately the paper does not report the coefficient used. Trial and error suggests a value around 4.305.
total number of risk factors =
= SUM(points for all 7 parameters)
Interpretation:
• minimum number of risk factors: 0
• maximum number of risk factors: 7
• The risk for lymphoma increases with the number of risk factors present.
Number of Risk Factors |
Percent with Lymphoma |
0 to 2 |
3.8% |
3 to 6 |
39.9% |
7 |
100% |
Specialty: Hematology Oncology